The following is a summary of “Unveiling the Prevalence and Impact of Silent Rhinovirus Infection in Chronic Rhinosinusitis with Nasal Polyps,” published in the January 2025 issue of Annals of Allergy ...

Degenerative disk disease is a progressive condition in which spinal disks deteriorate. Surgery is an option, but less invasive treatments and therapies may also help. Degenerative disk disease is ...

In asthma patients and patients with CRSwNP, these trials showed depemokimab could offer sustained inhibition of a key driver of their disease, and help achieve key clinical outcomes with a dosing ...

Thymic stromal lymphopoietin (TSLP) and interleukin (IL)-4 levels are elevated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and correlated with increased preoperative fractional ...

Systems immunology is beginning to transform sepsis care toward precision medicine approaches, including diagnostics to enable early detection and immune-directed therapies tailored for specific ...

CRSwNP affects up to 4% of the general population, with approximately 40% having uncontrolled disease. In Japan, about 200,000 people with chronic sinusitis are subject to surgery due to nasal polyps.

LONDON - GSK plc (LSE/NYSE: GSK) has announced the acceptance of regulatory filings in China and Japan for depemokimab, a new biologic treatment for asthma with type 2 inflammation and chronic ...

CRSwNP is a chronic inflammatory sinus disease, with 80% of patients showing evidence of the type 2 airway inflammation associated with more severe diseases and symptoms. Depemokimab is not currently ...

20 The phase III programme in CRSwNP includes two studies, ANCHOR-1 and ANCHOR-2. 2,3 Depemokimab is currently being evaluated in phase III trials for the treatment of other IL-5 mediated diseases, ...